ArticleFrontiers in pharmacology2022
A Phase Ib Study of the Simmitecan Single Agent and in Combination With 5-Fluorouracil/Leucovorin or Thalidomide in Patients With Advanced Solid Tumor.
Qi Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.